[1] Belli LS, Perricone G, Adam R, et al. Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry. J Hepatol, 2018, 69: 810-817.
[2] Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med, 2011, 365: 1790-1800.
[3] Consensus conference: indications for liver transplantation, January 19 and 20, 2005, lyon-palais des congrès: text of recommendations (long version). Liver Transpl, 2006,12:998-1011.
[4] Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology, 2005, 41:353-358.
[5] Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology, 2007, 45:1348-1354.
[6] Louvet A, Thursz MR, Kim DJ, et al. Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials. Gastroenterology, 2018, 155:458-468.
[7] Lee BP, Mehta N, Platt L, et al. A. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology, 2018, 155:422-430.
[8] Solga SF, Serper M, Young RA, et al. Transplantation for alcoholic hepatitis: are we achieving justice and utility? Hepatology, 2019, 69: 1798-1802.
[9] EASL Clinical Practice Guidelines. Management of alcohol-related liver disease. J Hepatol, 2018, 69: 154-181.
[10] Arab JP, Roblero JP, Altamirano J, et al. Alcohol-related liver disease: clinical practice guidelines by the Latin American association for the study of the liver (ALEH). Ann Hepatol, 2019, 18: 518-535.
[11] Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases. Hepatology, 2020, 71: 306-333.
[12] Mitchell MC, Friedman LS, McClain CJ. Medical management of severe alcoholic hepatitis: expert review from the clinical practice updates committee of the AGA institute. Clin Gastroenterol Hepatol, 2017, 15: 5-12.
[13] Lee BP, Samur S, Dalgic OO, et al. Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis. Gastroenterology, 2019, 157: 472-480.
[14] Mathurin P, Lucey MR. Liver transplantation in patients with alcohol related liver disease: current status and future directions. Lancet Gastroenterol Hepatol, 2020, 5:507-514.
[15] Tacke F, Kroy DC, Barreiros AP,et al. Liver transplantation in Germany. Liver Transpl, 2016, 22: 1136-1142.
[16] Antonini TM, Guillaud O, Dumortier J, et al. Impact of a first study of early transplantation in acute alcoholic hepatitis: results of a nationwide survey in French liver transplantation programs. Liver Transpl, 2018, 24:841-844.
[17] Bangaru S, Pedersen MR, MacConmara MP, et al. Survey of liver transplantation practices for severe acute alcoholic hepatitis. Liver Transpl, 2018, 24:1357-1362.
[18] Stroh G, Rosell T, Dong F, et al. Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation. Am J Transpl, 2015,15:1598-1604.
[19] Burra P, Bizzaro D, Forza G, et al. Severe acute alcoholic hepatitis: can we offer early liver transplantation. Minerva Gastroenterol Dietol, 2020, 67:23-25. |
